羟氯喹啉和阿奇霉素相关的心血管毒性：世界卫生组织药物警戒数据库分析 - Suppr

Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.

作者信息

Nguyen Lee S, Dolladille Charles, Drici Milou-Daniel, Fenioux Charlotte, Alexandre Joachim, Mira Jean-Paul, Moslehi Javid J, Roden Dan M, Funck-Brentano Christian, Salem Joe-Elie

机构信息

Sorbonne Université, Institut national de la santé et de la recherche médicale (INSERM), Assistance Publique - Hopitaux de Paris, Clinical Investigation Center, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France (L.S.N., C.F., C.F.-B., J.-E.S.).

Centre Medico-Chirurgical Ambroise Paré, Research & Innovation, Neuilly-sur-Seine, France (L.S.N.).

出版信息

Circulation. 2020 Jul 21;142(3):303-305. doi: 10.1161/CIRCULATIONAHA.120.048238. Epub 2020 May 22.

DOI:10.1161/CIRCULATIONAHA.120.048238

PMID:32442023

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7365677/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbd/7365677/7b299e6cfe8d/cir-142-303-g001.jpg

相似文献

Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.

Circulation. 2020 Jul 21;142(3):303-305. doi: 10.1161/CIRCULATIONAHA.120.048238. Epub 2020 May 22.

"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.

Therapie. 2020 Jul-Aug;75(4):371-379. doi: 10.1016/j.therap.2020.05.002. Epub 2020 May 7.

The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin.

Pharmacotherapy. 2020 Sep;40(9):978-983. doi: 10.1002/phar.2445. Epub 2020 Aug 4.

Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.

Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):108-111. doi: 10.1016/j.rec.2020.08.020. Epub 2020 Oct 1.

Hydroxychloroquine + azithromycin treatment in elderly patients.

Int J Antimicrob Agents. 2021 Apr;57(4):106313. doi: 10.1016/j.ijantimicag.2021.106313. Epub 2021 Mar 11.

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.

Res Social Adm Pharm. 2021 Feb;17(2):483-486. doi: 10.1016/j.sapharm.2020.04.016. Epub 2020 Apr 19.

Adverse drug reactions to chloroquine/hydroxychloroquine in combination with azithromycin in COVID-19 in-patients: data from intensive pharmacovigilance in Morocco, 2020.

Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3847-3856. doi: 10.1007/s00210-023-02574-7. Epub 2023 Jun 26.

QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine.

Eur J Clin Invest. 2020 Jun;50(6):e13258. doi: 10.1111/eci.13258. Epub 2020 May 18.

Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis.

J Nepal Health Res Counc. 2021 Apr 23;19(1):1-9. doi: 10.33314/jnhrc.v19i1.3270.

QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.

Arq Bras Cardiol. 2020 Jun;114(6):1061-1066. doi: 10.36660/abc.20200389. Epub 2020 Jul 3.

引用本文的文献

COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose-That Was the Question.

Viruses. 2025 Jun 23;17(7):881. doi: 10.3390/v17070881.

Drug-Drug Interactions of Hydroxychloroquine and Chloroquine in Older Patients with COVID-19 during the First Pandemic Waves: The GeroCovid Observational Study.

Reports (MDPI). 2024 May 23;7(2):42. doi: 10.3390/reports7020042.

Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023.

Sci Rep. 2025 Apr 17;15(1):13285. doi: 10.1038/s41598-025-98106-9.

Safety of Hydroxychloroquine: What a Dermatologist Should Know.

Am J Clin Dermatol. 2025 Mar;26(2):251-264. doi: 10.1007/s40257-025-00919-x. Epub 2025 Feb 3.

Global Burden of Vaccine-Associated Chronic Urticaria, 2010-2023: From the Global Pharmacovigilance Database.

Allergy Asthma Immunol Res. 2024 Nov;16(6):613-625. doi: 10.4168/aair.2024.16.6.613.

Global Perspective on COVID-19 Therapies, Cardiovascular Outcomes, and Implications for Long COVID: A State-of-the-Art Review.

J Community Hosp Intern Med Perspect. 2024 Mar 4;14(2):58-66. doi: 10.55729/2000-9666.1308. eCollection 2024.

Pattern of Antibiotic Prescriptions in Chinese Children, A Cross-Sectional Survey From 17 Hospitals Located Across 10 Provinces of China.

Front Pediatr. 2022 Jul 14;10:857945. doi: 10.3389/fped.2022.857945. eCollection 2022.

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions.

J Pharmacol Sci. 2023 May;152(1):1-21. doi: 10.1016/j.jphs.2023.02.004. Epub 2023 Feb 15.

Practices, knowledge, and attitudes of community pharmacists towards dispensing drugs during the COVID-19 pandemic: A cross sectional study from Jordan.

Pharm Pract (Granada). 2022 Jul-Sep;20(3):2692. doi: 10.18549/PharmPract.2022.3.2692. Epub 2022 Aug 6.

The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion.

J Infect Public Health. 2023 Jan;16(1):42-54. doi: 10.1016/j.jiph.2022.11.022. Epub 2022 Nov 19.

本文引用的文献

Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.

Arch Cardiovasc Dis. 2020 May;113(5):367-368. doi: 10.1016/j.acvd.2020.04.001. Epub 2020 Apr 15.

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.

Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.

Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes.

Circulation. 2019 Sep 24;140(13):1070-1080. doi: 10.1161/CIRCULATIONAHA.119.040162. Epub 2019 Aug 5.

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.

Lancet Oncol. 2018 Dec;19(12):1579-1589. doi: 10.1016/S1470-2045(18)30608-9. Epub 2018 Nov 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献